Insights

This study introduces a new method for detecting Multiple Sclerosis (MS) lesions and estimating brain atrophy using MRI scans. The technique aids in monitoring disease progression and brain volume loss over time.

Area of Science:

  • Medical Imaging
  • Neurology
  • Radiology

Background:

  • Multiple Sclerosis (MS) lesion detection and disease progression monitoring are crucial for patient management.
  • Accurate assessment of brain atrophy is essential for understanding MS progression.

Purpose of the Study:

  • To present a novel method for detecting MS plaques and estimating brain volume from MR images.
  • To enable simultaneous monitoring of MS disease progression and associated brain atrophy.

Main Methods:

  • A clustering-based approach was used to delineate MS plaques using anatomical, geometrical, and lesion features.
  • Brain Parenchymal Fraction (BPF) was calculated to quantify MS-related atrophy.
  • 3D FLAIR and T1-weighted MR images from 30 MS patients across two visits (baseline and 6-month follow-up) were utilized.

Main Results:

  • The proposed technique achieved a sensitivity of 73.80% in segmenting MS lesions.
  • Mean BPF at baseline was 0.82 ± 0.01, increasing slightly to 0.83 ± 0.01 at follow-up.
  • A minimal brain volume loss of 0.4% was observed between baseline and the 6-month follow-up.

Conclusions:

  • The developed method effectively detects MS lesions and quantifies brain atrophy.
  • This approach offers a valuable tool for monitoring MS progression and brain volume changes over time.

Related Concept Videos